That Ilara deal really helped the share price . Perhaps if RAP could show some nonGovt revenue and stop with the pilot study BS we might get back to 6c. God help us!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%